Interpace Diagnostics: High-Growth Small-Cap with Innovative Molecular Tests for Cancer

Nov. 2, 2017
Interpace Diagnostics (NASDAQ: IDXG) is a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology ...

 Read More

Bloomberg TV Show

CEO Interviews

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market